Kodiak Sciences Inc.
For the period ended Sep 30, 2025. Filed Nov 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 13, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
During our last fiscal quarter, one of our officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted a written plan for the sale of our securities set forth in the table below.
| Type of Trading Arrangement · Total Shares of | |||||
|---|---|---|---|---|---|
| Rule · Non-Rule · Common Stock | |||||
| Name and Position · Action · Adoption Date · 10b5-1* · 10b5-1** · to be Sold · Expiration Date | |||||
| John Borgeson, Chief Financial Officer | Adoption | September 29, 2025 | X | 120,000 | December 16, 2026 |
- Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
** “Non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K under the Securities Exchange Act.
Item 6. E
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.